ABEONA THERAPEUTICS INC. ABEO
ABEONA THERAPEUTICS INC. statistics & valuation
Market cap$319.7M
P / E4.5×
P / S54.9×
P / B2.0×
Net margin1223.1%
Return on equity44.7%
FCF margin-1448.5%
Net cash$58.4M
Enterprise value USD$261.3M
Earnings yield EBIT/EV-34.2%
Return on capital-47.1%
Graham number -0.9%$7.40
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($7.40); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -1536.9% | — | -1346.7% | -3600.8% | -2994.5% | -814.2% | — | -1940.2% | -3325.7% | -2686.3% |
| Net margin | 1223.1% | — | -1548.2% | -2807.4% | -2831.2% | -842.3% | — | -1890.3% | -3263.9% | -2460.4% |
| FCF margin | -1448.5% | — | -1066.9% | -3084.4% | -2327.2% | -363.6% | — | -1612.9% | -2809.4% | -1522.3% |
| Return on assets | 32.4% | -58.5% | -84.7% | -61.8% | -106.7% | -55.7% | -34.1% | -32.5% | -15.3% | -19.7% |
| Return on equity | 44.7% | -144.7% | -365.5% | -148.3% | -200.5% | -82.1% | -42.8% | -42.3% | -16.1% | -22.1% |
| Debt / equity | 0.13× | 0.43× | — | — | — | — | — | — | — | — |
| Current ratio | 6.93 | 6.08 | 4.15 | 6.83 | 3.39 | 2.33 | 3.42 | 4.37 | 25.07 | 8.37 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.